Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fusion Pharmaceuticals Inc (NQ: FUSN )

2.400 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Fusion Pharmaceuticals Inc

< Previous 1 2 3 Next >
Fusion Pharmaceuticals is Future Pillar of Cancer Treatment: Analyst
Raymond James has initiated coverage on Fusion Pharmaceuticals Inc (NASDAQ: FUSN) with an Outperform rating and a  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2023
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Recap: Fusion Pharmaceuticals Q1 Earnings
Via Benzinga
Fusion Pharmaceuticals Earnings Perspective: Return On Capital Employed
Via Benzinga
Fusion Pharmaceuticals's Return On Capital Employed Overview
Via Benzinga
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Avis Budget, Zoetis, Palantir Technologies And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded higher, with the Dow Jones gaining over 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Dow Falls 150 Points; US Consumer Prices Rise 0.5% In January
U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.46% to 34,089.44 while the NASDAQ fell 0.42%... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Fusion Pharma Raises $60M To Fund Acquisition Of Prostate Cancer-Targeted Radiopharmaceutical
Via Benzinga
Why Fusion Pharmaceuticals Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start another day of trading with a breakdown of the biggest pre-market stock movers investors need to watch for Tuesday! 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022
Via Benzinga
10 Best Stocks to Buy Now According to Jeffrey Diehl’s Adams Street Partners
In this article, we will be taking a look at some of the top stocks in the portfolio of Jeffrey Diehl. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022
  
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
  
Via Benzinga
Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday
Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Upgrades 
Via Benzinga
$1.7 Million Bet On Offerpad Solutions? Check Out These 3 Penny Stocks Insiders Are Buying
U.S. producer prices dropped 0.5% month-over-month in July, following a revised 1% increase in the previous month. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday, 52 stocks hit new 52-week lows. 
Via Benzinga
Fusion Pharmaceuticals: Q2 Earnings Insights
  Fusion Pharmaceuticals (NASDAQ:FUSN) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 15 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 73 companies hit new 52-week lows. 
Via Benzinga
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2022
Upgrades 
Via Benzinga
Looking Into Fusion Pharmaceuticals's Return On Capital Employed
Fusion Pharmaceuticals (NASDAQ:FUSN) brought in sales totaling $585.00 thousand during Q1 according to data provided by Benzinga Pro. However, earnings decreased 15.51%, resulting in a loss of $19.91... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 87 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 77 companies made new 52-week lows. 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.